ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
4 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension
Application Deadline: August 01, 2014
The Program is designed to support basic science and clinical research in the field of pulmonary arterial hypertension. Areas of research may include, but are not limited to:
Basic science underlying PAH
Genetics of PAH
Pathophysiology of PAH
Epidemiology of PAH
Techniques for early diagnosis of PAH
The Program is designed to support new original research. Proposals with significant scientific overlap with funded research projects from a peer review agency or industry source will not be considered.
Applicants must meet the following requirements:
Hold an MD, DO, PhD, or equivalent degree at time of award
Be within 5 years of a faculty appointment in association with a research institution in the United States at the time of application
Have a strong career interest in PAH
Have a research mentor with extensive experience in the field of PAH
Be able to devote at least 50% of professional time to research (versus administrative, patient care, or teaching responsibilities)
Be able to complete the proposed research within the 2-year award period
An applicant must be a citizen, permanent resident of the United States, or hold a temporary nonimmigrant visa. This visa must be valid for the two-year award period (January 2, 2015 – December 31, 2016).
Submission Deadline: Midnight, Eastern Daylight Time, August 1, 2014.
No applications will be accepted after this date.
Applications must be completed online and submitted electronically with the required Supplementary Materials.
Applications must include the following Supplementary Materials as specified:
Completed Application Form (All fields must be completed or applicant will not be able to submit)
Applicant's curriculum vitae, resume, or NIH biosketch, inclusive of publications, if applicable
Mentor's NIH biosketch
Letter of support from mentor, which includes: mentor’s track record of productivity, funding, and success with prior trainees; detailed description of the mentoring plan, including available resources allocated to the proposed research project, provision of protected time and available laboratory facilities
Bibliography of relevant references (maximum of 20)
Detailed budget and completed budget summary
Certification of Faculty Appointment from mentor is required and must be submitted with the Application using the template provided on the Program website (Download Certification of Faculty Appointment Template)
Acknowledgement of Indirect Costs Limitation and of the terms of this award from your institution's grants department is required and must be submitted using the template provided on the Program website)
List of Current or Pending Applications for Funding, using the template provided on the Program website
For general inquires about the Research Scholars Program, please call or email:
Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension
Attn: Research Scholars Program Coordinator
American Heart Association National Innovative Research Grant
Application Deadline: July 24, 2014
Award Activation: January 1, 2015
Applications must be received no later than 5:00 p.m. CDT on the deadline date. The system will shut down at 5:00 p.m. CDT. Early submission is encouraged. Your institutional Grants Officer (GO) has the final responsibility of submitting your completed application to the American Heart Association. It is important that you check with your GO for his/her internal deadline.
To support highly innovative, high-risk, high-reward research that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular and stroke research.
Research deemed innovative may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities. The Innovative Research Grant (IRG) promotes new ideas; therefore, proposals need not include preliminary data. However, a solid rationale for the work must be provided. Proposed work should not be the next logical step of previous work, but should have a high probability of revealing new avenues of investigation, if successful. This program aims to provide pilot or seed funding that should lead to successful competition for additional funding beyond the pilot period.
The principal investigator (PI) is responsible for clearly and explicitly articulating the project's innovation and the potential impact on cardiovascular and stroke research.
Research broadly related to cardiovascular function and disease and stroke, or to related clinical, basic science, bioengineering or biotechnology, and public health problems, including multidisciplinary efforts.
Proposals are encouraged from all basic, behavioral, epidemiological, and community and clinical investigations that bear on cardiovascular and stroke problems.
At the time of application, the applicant must:
• Hold an M.D., Ph.D., D.O. or equivalent doctoral degree.
Eligibility for the Innovative Research Grant is not restricted based upon experience level or seniority. Seniority will not be used as a criterion in evaluating an application's merit.
At the time of award activation, must:
• Have a faculty (or faculty equivalent) appointment. This award is not intended for postdoctoral fellows or others in research training positions.
At time of application, must have one of the following designations:
• U.S. citizen
• Permanent resident
• Pending permanent resident. Applicants must have applied for permanent residency and have filed form I-485 with the U.S. Citizenship and Immigration Services and have received authorization to legally remain in the United States (having filed an Application for Employment Form I-765).
• E3 - specialty occupation worker
• H-1B Visa - temporary worker in a specialty occupation
• J-1 Visa-exchange visitor. Note: You must have an H-1B or equivalent by the award activation date. If the H-1B or equivalent is not received by the award activation date, the award must be relinquished.
• O-1 Visa - temporary worker with extraordinary abilities in the sciences
• TN Visa - NAFTA professional
• G-4 Visa - family member of employee of international organizations and NATO
Awardee must meet American Heart Association citizenship criteria throughout the duration of the award.
Location of Work
National programs are open to all affiliates.
American Heart Association research awards are limited to non-profit institutions, including medical, osteopathic and dental schools, veterinary schools, schools of public health, pharmacy schools, nursing schools, universities and colleges, public and voluntary hospitals and other non-profit institutions that can demonstrate the ability to conduct the proposed research.
Applications will not be accepted for work with funding to be administered through any federal institution or work to be performed by a federal employee, except for Veterans Administration employees.
Applicants are not required to reside in the United States for any period before applying for American Heart Association funding.
Exception: An investigator may be allowed to request approval to conduct work outside the United States temporarily.
Total Annual Award Amount: $75,000
Award Duration: Two years
Contact us for questions/inquiries about programs and login issues/assistance.
American Heart Association
Division of Research Administration
AHA National Center
7272 Greenville Avenue
Dallas, TX 75231-4596
CHEST Foundation 2014 Grants and Awards Program
Each year, The CHEST Foundation offers CHEST members grants for clinical and translational research, leadership, and volunteer community service. Nearly 800 recipients worldwide have received more than $9 million to support and recognize outstanding work in chest medicine.
Application deadline: May 31
For more information, contact:
Dr. Sydney Parker, Director, Grants and Awards
Distinguished Scholar in Thrombosis Grant
GlaxoSmithKline Distinguished Scholar in Thrombosis
$150,000 awarded over 3 years
Application Deadline: May 31
The Distinguished Scholar in Thrombosis grant supports clinical educational projects to improve patient care and is intended for the investigation of issues that are not easily supported through traditional funding. The grant will support a Fellow of the American College of CHEST Physicians (FCCP) who is a recognized clinician and/or scientist with a specialty in thrombosis as evidenced by publications, presentations, and peers. The applicant must propose a thrombosis-related project that does one or more of the following:
• Investigates alternatives for treatment.
• Educates patients about options for diagnosis and treatment.
• Disseminates new knowledge about diagnosis and treatment.
• Defines new mechanisms leading to innovations and improvements to treatment.
Clinical Research Grants and Leadership Awards
The CHEST Foundation Clinical Research Grant in Lung Cancer
$100,000 awarded over 2 years
Application Deadline: May 31, 2014
This grant, establashed through a grant from Genetech, supports a clinical/translational research project that could lead to improved treatment and/or cure for lung cancer. Applicant must be a CHEST member who has completed at least 1 year of a pulmonary or critical care fellowship or a thoracic surgery residency and be within 7 years of completing training.
The CHEST Foundation Clinical Research Grant in Pulmonary Arterial Hypertension
$50,000 (July 2014 to June 2015)
This grant, established through a grant from Actelion Pharmaceuticals, US, Inc., supports a clinical/translational research project that contributes to the understanding of the pathophysiology or treatment of pulmonary arterial hypertension. Research must be completed between July 2014 and June 2015. Applicant must be a CHEST member who has completed at least 1 year of a pulmonary or critical care fellowship and be within 7 years of completing training.
The CHEST Foundation and The Pulmonary Fibrosis Foundation Clinical Research Grant in Pulmonary Fibrosis
$30,000 (July 2014 to June 2015)
This grant supports a clinical/translational research project that contributes to effective treatments or a cure for pulmonary fibrosis. Research must be completed between July 2014 and June 2015. Applicant must be a CHEST member who has completed at least 1 year of a pulmonary or critical care fellowship and be within 7 years of completing training.
Diversity Committee Young Investigator Faculty Scholar in Pulmonary, Cardiovascular, Critical Care, or Sleep Research Grant
$25,000 (July 2014 to June 2015)
This grant supports outstanding underrepresented young investigators in their careers in pulmonary, cardiovascular, critical care, or sleep research, with a focus on promoting equity and reducing disparity within a global setting. The grant supports clinical/translational research in pulmonary, cardiovascular, critical care, or sleep medicine. Research must be completed between July 2014 and June 2015.
Applicant must be a CHEST member who has completed at least 1 year of a pulmonary or critical care fellowship and be within 5 years of completing training.
The CHEST Foundation and Alpha-1 Foundation Clinical Research Grant in COPD and Alpha-1 Antitrypsin (AAT) Deficiency
This award supports research focused on COPD and AAT deficiency. While research projects primarily in usual COPD (not associated with AAT deficiency) are allowed, those with a focus on AAT deficiency are encouraged. Research must be completed between July 2014 and June 2015. Applicant must be a CHEST member who qualifies as a young investigator (ie, in an ACGME fellowship training programs and within 5 years of completion).
The CHEST Foundation and Respiratory Health Association Clinical Research Grant in Women’s Lung Health
$10,000 (July 2014 to June 2015)
This grant supports a clinical research project related to women’s lung health. Topics may include research on gender differences in lung diseases, such as COPD and lung cancer. Research must be completed between July 1, 2014 and June 30, 2015.
Applicant must be a CHEST member and hold the degree of MD, DO, MBBCh, PharmD, PhD, or the equivalent.
Community Service and Humanitarian Grants
McCaffree Community Service and Humanitarian Grants
$5,000 to $15,000
The McCaffree Community Service and Humanitarian grants are given for community-based projects supported by the service work of CHEST members worldwide. Projects must show a clear impact on the community and have the potential for long-term sustainability and replicability. Grant funds are paid to the nonprofit or nongovernmental organization where the member donates time and medical service.
International Society for Heart Research Richard J. Bing Award for Young Investigators
The Richard J. Bing Award for Young Investigators is given at each World Congress of the International Society for Heart Research. The purpose of this Award is to recognize outstanding endeavors by new investigators in research activities, and to encourage continued biomedical research careers broadly related to cardiovascular biology. Details of the competition are as follows:
1. Candidates must be active members (or have applied for membership) of the ISHR (membership application forms are available on the ISHR website at www.ishrworld.org or from Dr. Richard L. Moss, Sec Gen ISHR, Senior Assoc Dean, Basic Research, Biotechnology and Graduate Studies, Univ of Wisconsin School of Medicine and Public Health, 750 Highland Ave, Madison, WI, 53705, USA; ph: 608-265-0523, fax: 608-265-0522, email: email@example.com).
2. Candidates must have received their Ph.D. (or equivalent) less than 6 years prior to the opening day of the Congress. Allowance will be made for career breaks. It is the responsibility of the candidate and supervisor to justify the degree of disruption to the career.
3. Applications must include the following:
• An original manuscript in any area of cardiovascular biology
• A curriculum vitae
• A statement detailing how much of the design and research work was done by the candidate and by any co-investigators. This statement must be endorsed by the candidate’s immediate supervisor (e.g., Division Head, Department Chairman, or Institute Director). In case of multi-authored manuscripts, the supervisor should also indicate that among all of the co-authors, the applicant is the most appropriate candidate for the Award, and offer rationale for this opinion.
All of these items should be provided in electronic format, as PDF files on a single flash drive. A printed copy of the supervisor's statement letter, with original signature, should also accompany the nomination.
6. The manuscript must be unpublished (as defined by not having appeared on PubMed) by the closing date for submissions for the Award.
7. The application materials must be received by Dr. Richard L. Moss, Sec Gen ISHR, Senior Assoc Dean, Basic Research, Biotechnology and Graduate Studies, Univ of Wisconsin School of Medicine and Public Health, 750 Highland Ave, Madison, WI, 53705, USA; ph: 608-265-0523, fax: 608-265-0522, email: firstname.lastname@example.org, no later than February 1, 2016. Applications received after that date will not be considered.
8. Only one submission per author will be considered. The candidate must be the sole or the first author of the manuscript submitted.
9. Four finalists will be selected from the submitted works by a Committee of the ISHR. Each finalist will qualify for a travel award of up to a maximum of US$1,500 [to include coach class travel and a maximum of 3 nights’ hotel accommodation] when the Award recipient delivers their oral presentation at a World Congress in his/her region, and up to a maximum of US$3,000 when inter-continental travel is required. All finalists will receive a free electronic subscription to the Journal of Molecular and Cellular Cardiology. A photograph and biosketch of the winner will be published in Heart News and Views, and will be posted in the ISHR website.
10. At the Congress, each finalist will verbally present his/her study to the Society. The winner of the Award will receive a plaque and a cash award of US$1,500. The three runner-ups will receive a plaque and a cash award of US$1,000.
11. Any finalist who, for any reason, cannot personally present his or her work must withdraw from the competition. Substitute presenters are not allowed.
12. Submitted manuscripts will not be returned.